Clin2
NCT07690163Possibly a fitRecruiting

Diabetes blood sugar check in newly diagnosed patients

Type 2 Diabetes (T2DM)Obesity Type 2 Diabetes MellitusObesity & OverweightInsulin Resistance

Part of Hormones & metabolism clinical trials.

This trial is checking how well blood sugar is controlled in adults recently diagnosed with type 2 diabetes (within the last 3 months). It aims to see if current treatments or lifestyle changes are working and may help guide future care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
80 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 or older.
  • You must have been diagnosed with type 2 diabetes within the last 3 months.
  • Your blood sugar level (HbA1c) must be between 6.5% and 9.5% at the time of screening.
  • You may be managing diabetes with lifestyle changes or certain diabetes pills (like metformin or others, but not insulin).
  • You must not have ever used insulin therapy.
  • You cannot have serious diabetes complications (like kidney problems, foot ulcers, or severe nerve damage).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07599072Recruiting
Blood Sugar Monitoring Study for Prediabetes

This study tracks how blood sugar levels change in people with prediabetes (higher-than-normal blood sugar but not yet diabetes). Researchers will use a small sensor to monitor your blood sugar and help understand what affects it, which could help prevent or delay type 2 diabetes.

Kyiv
NCT07679347Not yet recruiting
Testing a new continuous glucose monitor for type 1 diabetes

This trial tests a new continuous glucose monitor (CGM) designed to help manage blood sugar levels. You will wear the device for 15 days and attend three clinic visits to see how well it works.

NCT07092761Recruiting
Testing a new continuous glucose monitor

This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.

Luoyang, Henan
NCT06471699Not yet recruiting
Continuous glucose monitor for newly diagnosed type 2 diabetes

This study tests whether using a continuous glucose monitor (CGM) helps people who were just diagnosed with type 2 diabetes manage their blood sugar better. Participants wear a small sensor on their arm that checks sugar levels all the time.

NCT07606066Recruiting
Finding Type 2 Diabetes Patients for Future Research Studies

This is a screening study to identify and understand people with type 2 diabetes whose blood sugar isn't well controlled, so they can potentially join future diabetes research trials. You won't receive a new treatment in this study—it's about getting to know your health history and seeing if you might be a good fit for upcoming studies.

Peoria, Arizona
NCT06825182Recruiting· Phase 3
Islet alpha cell function in new type 2 diabetes

This trial looks at how certain cells in the pancreas work in people newly diagnosed with type 2 diabetes. It may help doctors understand the disease better and find new treatment approaches.

Nanjing, Jiangsu

Hear when a new Type 2 Diabetes (T2DM) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.